GD-20

N/A

Report date: 2026/03/12 14:44:47
NME

Base Information

Drug NameGD-20
Drug Alias NameGD-20GD20
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuromyelitis OpticaMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTianjin Gudui Biopharma Tech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTianjin Gudui Biopharma Tech Inc
Inactive CompaniesN/A
Active IndicationsMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuromyelitis OpticaMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A